Elkin Muñoz, M.D., Ph.D.

Director of IVI Vigo

IVI Vigo

Elkin Muñoz, M.D., Ph.D.

Biography

Dr. Elkin Muñoz, MD, is the Chief Medical Officer of IVI Vigo and IVI Coruña Clinics, Assistant Professor at Vigo University in the Master’s Degree Program in Advanced Biotechnology with focus in assisted reproduction. He studied medicine at the University of Cauca (Colombia) where he also completed his residency in Obstetrics and Gynecology.

Dr. Muñoz obtained two Master’s degrees on Human Reproduction, one at University of Valencia and the second one at University Rey Juan Carlos. Since then, he also completed Master’s programs in laboratory procedures in reproduction (2015) and in clinical research (2017) at the European Health School, University Rey Juan Carlos. Dr. Muñoz has always been intensely interested in regularly academic training; he obtained a university-based certificate on gynecologic and breast ultrasonography, a postgraduate degree in gynecologic oncology and an additional diploma in medical genetics at University of Valencia. He did his post-doctoral training in reproductive medicine and gynecological endocrinology at IVI Valencia and obtained his Medicine and Surgery doctorate degree in 2015 in the Pediatrics, Obstetrics and Gynecology Department of the University of Valencia.
Dr. Muñoz is currently directing and supervising the following thesis project “Overall survival and disease-free survival in breast cancer patients under Controlled Ovarian Stimulation”. Dr. Munoz has received a large number of research-dissertation honors and recognitions, and has been awarded the “Alejandro Novo González Prize” in a couple of editions. In addition, European Society of Human Reproduction and Embryology (ESHRE) has also nominated Dr. Muñoz on several occasions.
Dr. Muñoz is a member of the Spanish Reproductive Society, where he is an active participant in the Spanish Reproductive Endocrinology Interest Group, and leads an online course titled “Polycystic ovary syndrome throughout a woman´s life”. He is also actively involved in the European Society of Human Reproduction and Embryology (ESHRE), in several Colleges of Physicians (Almería, Pontevedra) and in The American Society for Reproductive Medicine (ASRM).
Dr. Munoz’s research interests include embryonic implantation, fertility preservation, reproductive endocrinology, and genetics. He has published over 20 peer-reviewed articles in leading reproductive journals and wrote more than 15 book chapters. He also serves as Ad Hoc Reviewer for reproductive journals, and is an invited speaker at national and international scientific meetings.

Read more

Education and Training

M.D. University of Cauca (1990) Colombia
Residency University of Cauca (1995) Colombia
Ph.D. University of Valencia (2015) Spain

Honors and recognition

Society for Reproductive Endocrinology and Infertility (SREI) Prize Paper Award as ERA RCT Consortium Member- at ASRM 2016
33rd Alejandro Novo González Communication Award 2016
6th Congresso Portugues de Medicina da Reproduçao. Communication Award 2016
29th National congress SEF. Communication Award 2012
27th Annual Meeting ESHRE. Poster Award Nomination 2011
25th Annual Meeting ESHRE. Poster Award Nomination 2009
63rd Congreso da sociedade Galega de Obstetricia e Xinecoloxia. Communication Award. 2008
62nd Congreso da sociedade Galega de Obstetricia e Xinecoloxia. Communication Award 2007

Publications


  • ART complications (II). Ovarian hyperstimulation syndrome: diagnosis. Infertility and Assisted Reproduction. Algorithms for taking decisions.
    Muñoz E, González N, Aguilar J, Fernández I, Portela S, Remohí J.
    pp.239-242. Editorial médica Panamericana, S.A. 2016.

  • Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate.
    Aguilar J, Rubio I, Muñoz E, Pellicer A, Meseguer M.
    Fertil Steril, 106:291-299, 2016.

  • Strategies to manage refractory endometrium: state of the art in 2016.
    García-Velasco J. A, Acevedo B, Alvarez C, Alvarez M, Bellver J, Fontes J, Landeras J, Manau D, Martínez F, Muñoz E, Robles A, Rodríguez-Tabernero L. Reproductive BioMedicine Online. 32:474-489, 2016.

  • Ovarian Stimulation in Cancer Patients.
    Muñoz E, González N, Aguilar J, Muñoz L, García Velasco J.A.
    Fertility Preservation Basic Principles.50-55, 2016.

  • Ovarian stimulation in patients with breast cancer.
    Muñoz E, González N, Muñoz L, Aguilar J, García-Velasco J.A. Ecancermedicalscience. Creative Commons Attribution License. 1-9, 2015.

  • Oocyte donation outcome after oncological treatment in cancer survivors.
    Muñoz E, Fernández I, Martínez M, Tocino A, Portela S, Pellicer A, García-Velasco J. A, Garrido N.
    Fertil Steril,103:205-213, 2015.

  • The human first cell cycle: impact on implantation.
    Aguilar J, Motato Y, Escribá MJ, Ojeda M, Muñoz E, Meseguer M. Reproductive Bio Medicine Online. 475-484, 2014.

  • Treatment of Luteal Phase Defects in Assisted Reproduction. Current Drug Targets.
    Muñoz E, Taboas E, Portela S, Aguilar J, Fernández I, Muñoz L, Bosch E. Benthan Science Publishers. 14:832-842, 2013.

  • The role of LH in Ovarian Stimulation.
    Muñoz E, Bosch E, Fernández E, Portela S, Ortiz G, Remohí J, Pellicer A. Current Pharmaceutical Biotechnology. 13:409-416, 2012.


  • Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J, Guillén V, Martínez M, Muñoz E, Pellicer A, García-Velasco J. A.
    Fertil Steril,97:930-934,2012.

  • The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo- controlled trial.
    Busso C, Fernández-Sánchez M, García- Velasco J A, Landeras J, Ballesteros A, Muñoz E, González S, Simón C, Arces J, Pellicer A.
    Human Reproduction.1-10, 2010.

  • Pregnancy in patients with premature ovarian failure.
    Muñoz E, Portela S, Remohí J, Pellicer A.
    Expert Rev Obstet Gynecol. pp 711-714, 2007.

  • The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion.
    Bellver J, Reis S, Álvarez C, Muñoz E, Ramírez J A, Rubio C, Serra V, Remohí J, Pellicer A.
    Human Reproduction. 1-7, 2007.

  • Intravenous albumin did not prevent ovarian hyperstimulation syndrome in vitro fertilization cycles.
    Bellver J, Muñoz E, Ballesteros A, Reis S, Bosch E, Simón C, Pellicer A, Remohí J.
    Evidence-based Obstetrics and Gynecology. 6:194-195, 2004.

  • Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study.
    Bellver J, Muñoz E, Ballesteros A, Reis S, Bosch E, Simon C, Pellicer A, Remohi J.
    Human Reproduction, 18: 2283-2288, 2003.

  • El uso de FSH recombinante a dosis de 100 UI por día alcanza resultados similares a 150 UI en inseminación intrauterina (IUI).
    Muñoz E, García-Velasco J, Scheffer B, Muñoz M, Remohí J, Pellicer A, Simón C.
    Revista Iberoamericana de Fertilidad, 19: 253-259, 2002.

  • Two and Three-dimensional ultrasound in malformations of the medullary canal: report of four cases.
    Bonilla-Musoles F, Machado L, Osborne N, Muñoz E, Raga F, Blanes J, Bonilla F.
    Prenatal Diagnosis, 21:1-6, 2001.

  • Evaluación de la pareja estéril.
    Remohí J, Muñoz E, Navarro J, Gaytan J, Simon C, Pellicer A.
    Salud total en la mujer, pp. 24-34, 2001.

  • El clínico comenta: Soporte de fase lútea en fertilización in-vitro.
    Muñoz E, Remohí J.
    Sociedad Española de Fertilidad. Boletin SEF ,9:46-48, 2000.

  • Síndrome Antifosfolipídico y Reproducción Asistida: a propósito de un caso.
    Ibérico G, Crespo J, Serra V, Lara C, Muñoz E, Simon C, Pellicer A, Remohi J.
    Revista Iberoamericana de Fertilidad, 17: 167-174, 2000.

  • Infección por el virus de la hepatitis C y embarazo.
    Muñoz E, Valbuena D, Landazabal A, Remohi J, Pellicer A y Simon C. Progresos de Obstetricia y Ginecología, 43:105-116, 2000.

  • Metformina y troglitazona en el síndrome de ovario poliquístico.
    Vergara F, Muñoz E, Alvarez JC, Simon C, Remohi J. y Pellicer A.
    Revista Iberoamericana de Fertilidad, 16: 19-26, 2000.

  • Síndrome de hiperestimulación ovárica y accidentes cerebrovasculares: a propósito de un caso.
    Muñoz E, Alvarez JC, Landazabal A, Diaz I, Crespo J, Simon C, Pellicer A, Remohi J.
    Revista Iberoamericana de Fertilidad, 16: 239-244, 2000.

Read more
Close Menu